(GCO) Genesco - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US3715321028

GCO: Footwear, Apparel, Accessories

Genesco Inc. (NYSE:GCO) is a leading retailer and wholesaler of footwear, apparel, and accessories, operating across the United States, Puerto Rico, Canada, the United Kingdom, and the Republic of Ireland. The company is organized into four distinct segments: Journeys Group, Schuh Group, Johnston & Murphy Group, and Genesco Brands. The Journeys Group focuses on footwear and accessories for young men, women, and children, operating through retail chains like Journeys, Journeys Kidz, and Little Burgundy, as well as e-commerce platforms. The Schuh Group specializes in casual and athletic footwear, with a strong presence in retail stores and online channels. Johnston & Murphy Group combines retail and e-commerce operations with wholesale distribution, offering mens dress and casual footwear, apparel, and accessories, alongside womens footwear. Genesco Brands markets footwear under licensed brands such as Levis, Dockers, and G.H. Bass, while also designing and manufacturing footwear under the STARTER brand. The company operates multiple e-commerce websites, including journeys.com, schuh.co.uk, and johnstonmurphy.com. Founded in 1934, Genesco is headquartered in Nashville, Tennessee.

Based on current and , Genesco Inc. is expected to face a challenging environment over the next three months. Technically, the stock price of $36.21 is below its SMA 20 ($39.38) and SMA 50 ($40.92), indicating bearish momentum. The SMA 200 ($31.57) suggests potential support near $30, while resistance is likely at $42. With an ATR of 1.91, volatility is moderate. Fundamentally, the companys forward P/E of 18.73 reflects elevated valuations, while a P/S ratio of 0.18 indicates undervaluation relative to revenue. However, the negative RoE (-5.03%) signals profitability challenges. The market cap of $411.27M and P/B ratio of 0.81 suggest cautious investor sentiment. Over the next quarter, GCO is likely to test support near $30 and resistance at $42, with downside risks tied to weak earnings and high valuations. The companys ability to manage debt and improve inventory turnover will be critical in navigating this period.

Additional Sources for GCO Stock

GCO Stock Overview

Market Cap in USD 222m
Sector Consumer Cyclical
Industry Apparel Retail
GiC Sub-Industry Apparel Retail
IPO / Inception 1985-07-01

GCO Stock Ratings

Growth Rating 2.67
Fundamental 1.41
Dividend Rating 0.0
Rel. Strength -32.7
Analysts 3/5
Fair Price Momentum 18.04 USD
Fair Price DCF 91.04 USD

GCO Dividends

No Dividends Paid

GCO Growth Ratios

Growth Correlation 3m -93.8%
Growth Correlation 12m 14.7%
Growth Correlation 5y -19.8%
CAGR 5y 3.77%
CAGR/Max DD 5y 0.05
Sharpe Ratio 12m -0.96
Alpha -40.85
Beta 2.081
Volatility 55.46%
Current Volume 166.1k
Average Volume 20d 356.9k
What is the price of GCO stocks?
As of April 26, 2025, the stock is trading at USD 20.08 with a total of 166,118 shares traded.
Over the past week, the price has changed by +4.69%, over one month by -11.11%, over three months by -52.30% and over the past year by -23.01%.
Is Genesco a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Genesco is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 1.41 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GCO as of April 2025 is 18.04. This means that GCO is currently overvalued and has a potential downside of -10.16%.
Is GCO a buy, sell or hold?
Genesco has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold GCO.
  • Strong Buy: 0
  • Buy: 0
  • Hold: 2
  • Sell: 0
  • Strong Sell: 0
What are the forecast for GCO stock price target?
According to ValueRays Forecast Model, GCO Genesco will be worth about 19.8 in April 2026. The stock is currently trading at 20.08. This means that the stock has a potential downside of -1.29%.
Issuer Forecast Upside
Wallstreet Target Price 27 34.5%
Analysts Target Price 40 99.2%
ValueRay Target Price 19.8 -1.3%